Operating Segments (Tables)

6 Months Ended

Jun. 30, 2020

Segment Reporting [Abstract]

Schedule of operating segments

	Three Months Ended June 30,
	2020			2019
Revenues
Public Health Solutions	$	468,009		$	1,095,865
Specialized BioTherapeutics		37,279			449,099
Total	$	505,288		$	1,544,964
Income/(Loss) from Operations
Public Health Solutions	$	(50,737	)	$	204,121
Specialized BioTherapeutics		(1,808,652	)		(1,462,334	)
Corporate		(954,483	)		(905,678	)
Total	$	(2,813,872	)	$	(2,164,891	)
Amortization and Depreciation Expense
Public Health Solutions	$	7,318		$	4,316
Specialized BioTherapeutics		3,167			4,168
Corporate		7,317			4,448
Total	$	17,802		$	12,932
Other Income, Net
Specialized BioTherapeutics	$	35,091		$	(2,339	)
Corporate		2,018			43,709
Total	$	37,109		$	41,370
Share-Based Compensation
Public Health Solutions	$	8,377		$	8,072
Specialized BioTherapeutics		18,962			19,094
Corporate		53,664			45,726
Total	$	81,003		$	72,892

	Six Months Ended June 30,
	2020			2019
Revenues
Public Health Solutions	$	1,376,818		$	1,776,218
Specialized BioTherapeutics		53,024			913,534
Total	$	1,429,842		$	2,689,752
Income/(Loss) from Operations
Public Health Solutions	$	(209,239	)	$	195,110
Specialized BioTherapeutics		(9,166,503	)		(2,798,891	)
Corporate		(1,911,919	)		(1,861,173	)
Total	$	(11,287,661	)	$	(4,464,954	)
Amortization and Depreciation Expense
Public Health Solutions	$	14,621		$	8,718
Specialized BioTherapeutics		6,237			8,845
Corporate		14,590			5,429
Total	$	35,448		$	22,992
Other Income, Net
Specialized BioTherapeutics	$	68,706		$	2,670
Corporate		23,965			88,460
Total	$	92,671		$	91,130
Share-Based Compensation
Public Health Solutions	$	17,842		$	13,268
Specialized BioTherapeutics		44,251			40,002
Corporate		82,601			99,195
Total	$	144,694		$	152,465

	As of		As of
	June 30,		December 31,
	2020		2019
Identifiable Assets
Public Health Solutions	$	273,943	$	1,018,673
Specialized BioTherapeutics		86,639		41,705
Corporate		11,900,092		6,714,982
Total	$	12,260,674	$	7,775,360